Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Debt Ratio (2016 - 2025)

IGC Pharma (IGC) has disclosed Debt Ratio for 15 consecutive years, with 0.01 as the latest value for Q3 2025.

  • Quarterly Debt Ratio rose 4.06% to 0.01 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.01 through Sep 2025, up 4.06% year-over-year, with the annual reading at 0.02 for FY2025, 10.73% up from the prior year.
  • Debt Ratio for Q3 2025 was 0.01 at IGC Pharma, down from 0.02 in the prior quarter.
  • The five-year high for Debt Ratio was 0.02 in Q2 2025, with the low at 0.0 in Q2 2021.
  • Average Debt Ratio over 5 years is 0.01, with a median of 0.01 recorded in 2023.
  • Peak annual rise in Debt Ratio hit 837.39% in 2021, while the deepest fall reached 80.44% in 2021.
  • Over 5 years, Debt Ratio stood at 0.0 in 2021, then surged by 48.52% to 0.01 in 2022, then soared by 74.46% to 0.01 in 2023, then rose by 20.43% to 0.01 in 2024, then dropped by 8.22% to 0.01 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.01, 0.02, and 0.02 for Q3 2025, Q2 2025, and Q1 2025 respectively.